Ian S. Watts

730 total citations
19 papers, 636 citations indexed

About

Ian S. Watts is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pharmacology. According to data from OpenAlex, Ian S. Watts has authored 19 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Ian S. Watts's work include Nitric Oxide and Endothelin Effects (10 papers), Inflammatory mediators and NSAID effects (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Ian S. Watts is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Inflammatory mediators and NSAID effects (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Ian S. Watts collaborates with scholars based in United Kingdom, Germany and United States. Ian S. Watts's co-authors include David G. White, Michael Sumner, Patrick Vallance, Jan Riezebos, G. P. Lewis, P. J. Lumley, Alan G. Roach, G.M. Drew, Y.S. Bakhle and David M. Penny and has published in prestigious journals such as Blood, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Ian S. Watts

19 papers receiving 613 citations

Peers

Ian S. Watts

PHYSI

CCM

PRM

PHARM

Y. Notsu Japan

Osamu Suda Japan

T. Burke-Wolin United States

PJ Kadowitz United States

Graham H. Allcock United Kingdom

M H Yacoub United Kingdom

Yoshikatsu Tabuchi Japan

J. D. ELLIOTT United States

Pmgr Vanhoutte United States

Clemens Mittmann Germany

Y. Notsu Japan

Ian S. Watts

320 ×0.7

PHYSI

133 ×0.4

CCM

305 ×1.5

73 ×0.8

PRM

51 ×0.8

PHARM

Citations per year, relative to Ian S. Watts Ian S. Watts (= 1×) peers Y. Notsu

Countries citing papers authored by Ian S. Watts

Since Specialization

Citations

This map shows the geographic impact of Ian S. Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian S. Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian S. Watts more than expected).

Fields of papers citing papers by Ian S. Watts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian S. Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian S. Watts. The network helps show where Ian S. Watts may publish in the future.

Co-authorship network of co-authors of Ian S. Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Ian S. Watts. A scholar is included among the top collaborators of Ian S. Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian S. Watts. Ian S. Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jarvis, Gavin E., Robert G. Humphries, Ian P. Kirk, et al.. (1999). The P-2t antagonist AR-C69931MX is a more effective inhibitor of ADP-induced platelet aggregation than clopidogrel.. Blood. 94. 12 indexed citations

Riezebos, Jan, Ian S. Watts, & Patrick Vallance. (1994). Endothelin receptors mediating functional responses in human small arteries and veins. British Journal of Pharmacology. 111(2). 609–615. 79 indexed citations

Rabe, Klaus F., et al.. (1994). Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005. European Journal of Pharmacology. 260(2-3). 221–225. 26 indexed citations

Christodoulou, Chris, Kenneth L. Clark, Colin W. Dykes, et al.. (1994). Characterization of three non‐peptide endothelin receptor ligands using human cloned ET_A and ET_B receptors. British Journal of Pharmacology. 112(4). 1251–1257. 20 indexed citations

White, David G., et al.. (1994). Human saphenous vein contains both endothelin ETA and ETB contractile receptors. European Journal of Pharmacology. 257(3). 307–310. 43 indexed citations

White, David G., et al.. (1993). The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture. British Journal of Pharmacology. 109(4). 1128–1132. 8 indexed citations

White, David G., et al.. (1993). The effect of N^G‐nitro‐l‐arginine methyl ester upon basal blood flow and endothelium‐dependent vasodilatation in the dog hindlimb. British Journal of Pharmacology. 108(3). 763–768. 35 indexed citations

Sumner, Michael, et al.. (1993). Human Placental Membranes Contain Predominantly ETB Receptors. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S136–S139. 5 indexed citations

Trezise, Derek J., G.M. Drew, Alan G. Roach, Ian S. Watts, & A.H. Weston. (1993). Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia. European Journal of Pharmacology. 250(1). 109–116. 5 indexed citations

10.

White, David G., et al.. (1993). Endothelin ETA and ETB Receptors Mediate Vascular Smooth-Muscle Contraction. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S144–S148. 50 indexed citations

11.

Sumner, Michael, et al.. (1992). Endothelin ET_A and ET_B receptors mediate vascular smooth muscle contraction. British Journal of Pharmacology. 107(3). 858–860. 250 indexed citations

12.

Watts, Ian S., David G. White, Jill Coates, Richard C. E. Anderson, & Peter Strong. (1992). Fasting in the rat does not induce hyperfibrinogenaemia. Biochemical Pharmacology. 44(10). 2086–2087. 1 indexed citations

13.

Watts, Ian S., et al.. (1991). Thromboxane (Tx) A₂ receptor blockade and TxA₂ synthase inhibition alone and in combination: comparison of anti‐aggregatory efficacy in human platelets. British Journal of Pharmacology. 102(2). 497–505. 35 indexed citations

14.

Campbell, Ian B., E. W. COLLINGTON, Harry Finch, et al.. (1991). Synthesis and pharmacological evaluation of combined Thromboxane receptor antagonists/thromboxane synthase inhibitors: Pyridine-containing amino-prostanoids. Bioorganic & Medicinal Chemistry Letters. 1(12). 695–698. 4 indexed citations

15.

Campbell, Ian B., E. W. COLLINGTON, Harry Finch, et al.. (1991). Synthesis and pharmacological evaluation of combined thromboxane receptor antagonist/synthase inhibitors: pyridine-containing sulphonamido acids. Bioorganic & Medicinal Chemistry Letters. 1(12). 699–704. 8 indexed citations

16.

Watts, Ian S., et al.. (1989). Differential Ability of Agonists to Express Distinct Pools of Fibrinogen (Gpllb/llla) Receptors which Can Mediate the Aggregation of Human Platelets. Thrombosis and Haemostasis. 62(3). 955–961. 5 indexed citations

17.

Watts, Ian S., et al.. (1982). Altered prostaglandin synthesis in isolated lungs of rats with streptozotocin-induced diabetes. Thrombosis Research. 28(3). 333–342. 21 indexed citations

18.

Lewis, G. P. & Ian S. Watts. (1982). PROSTAGLANDIN ENDOPEROXIDES, THROMBOXANE A₂ AND ADENOSINE DIPHOSPHATE IN COLLAGEN‐INDUCED AGGREGATION OF RABBIT PLATELETS. British Journal of Pharmacology. 75(4). 623–631. 28 indexed citations

19.

Lewis, G. P., et al.. (1981). Role Of Thromboxane (TXA2 ) And Adp In Collagen-Induced Platelet Aggregation. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact